SU812298A1 - Method of treating patients with hypotolamyc syndrome - Google Patents
Method of treating patients with hypotolamyc syndrome Download PDFInfo
- Publication number
- SU812298A1 SU812298A1 SU752183910A SU2183910A SU812298A1 SU 812298 A1 SU812298 A1 SU 812298A1 SU 752183910 A SU752183910 A SU 752183910A SU 2183910 A SU2183910 A SU 2183910A SU 812298 A1 SU812298 A1 SU 812298A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- treatment
- electrophoresis
- patients
- syndrome
- moistened
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 20
- 208000011580 syndromic disease Diseases 0.000 title description 3
- 238000001962 electrophoresis Methods 0.000 claims description 9
- 208000018548 hypothalamic dysfunction Diseases 0.000 claims description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
- 210000004705 lumbosacral region Anatomy 0.000 claims description 5
- FQPFAHBPWDRTLU-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=C1NC=N2.O=C1N(C)C(=O)N(C)C2=C1NC=N2 FQPFAHBPWDRTLU-UHFFFAOYSA-N 0.000 claims description 4
- 208000035475 disorder Diseases 0.000 claims description 4
- 229960003556 aminophylline Drugs 0.000 claims description 3
- 230000002490 cerebral effect Effects 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- 239000011630 iodine Substances 0.000 claims description 3
- 150000002632 lipids Chemical class 0.000 claims description 3
- 230000002182 neurohumoral effect Effects 0.000 claims description 3
- 238000000554 physical therapy Methods 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 230000023555 blood coagulation Effects 0.000 claims description 2
- 235000012000 cholesterol Nutrition 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims 3
- 239000000243 solution Substances 0.000 claims 3
- 230000004060 metabolic process Effects 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- 208000024539 Diencephalic syndrome Diseases 0.000 claims 1
- 241000288140 Gruiformes Species 0.000 claims 1
- 208000037656 Respiratory Sounds Diseases 0.000 claims 1
- 210000003403 autonomic nervous system Anatomy 0.000 claims 1
- 208000020450 carbohydrate metabolism disease Diseases 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 206010014599 encephalitis Diseases 0.000 claims 1
- 238000002474 experimental method Methods 0.000 claims 1
- 239000004744 fabric Substances 0.000 claims 1
- 230000002267 hypothalamic effect Effects 0.000 claims 1
- 208000017745 inborn carbohydrate metabolic disease Diseases 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 230000030214 innervation Effects 0.000 claims 1
- 230000000926 neurological effect Effects 0.000 claims 1
- 206010037833 rales Diseases 0.000 claims 1
- 230000002782 sympathoadrenal effect Effects 0.000 claims 1
- 201000005665 thrombophilia Diseases 0.000 claims 1
- 230000000004 hemodynamic effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000018152 Cerebral disease Diseases 0.000 description 1
- 206010014612 Encephalitis viral Diseases 0.000 description 1
- 206010020608 Hypercoagulation Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- 230000003027 hypercoagulation Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229940053973 novocaine Drugs 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
. t . t
Изобретение относитс к медицине, в частности к способам физиотерапии, и может быть использовано при,лечении больных гипoтaлa личecким синдромом , например, развившимс после вирусного энцефалита.The invention relates to medicine, in particular, to methods of physiotherapy, and can be used in the treatment of patients with a hypothalosis by a personal syndrome, for example, developed after viral encephalitis.
Санаторно-курортное лечение больных с послеинфекционными гипоталамическими синдромами осуществл етс в различных климатических зонах. При этом используетс комплексное воздействие различных методов, в частности электрофореза кальци , новокаина, димедрола , салицилового натри , аминазина 1.Sanatorium-resort treatment of patients with post-infectious hypothalamic syndromes is carried out in different climatic zones. In this case, a complex effect of various methods is used, in particular, electrophoresis of calcium, novocaine, Dimedrol, salicylic sodium, aminazine 1.
Однако лечебные комплексы курортных факторов в сочетании с физиотерапевтическими методами используютс не достаточно дифференцированно. Воз можность их использовани находитс в зависимости от нейрогуморальных, обменных нарушений, расстройств церебральной гемодинамики.However, the therapeutic complexes of resort factors, in combination with physiotherapeutic methods, are not used sufficiently differentiated. The possibility of their use depends on neurohumoral, metabolic disorders, disorders of cerebral hemodynamics.
Наиболее близким к изобретению вл етс способ комплексного курортноклиматического лечени больных гипоталамическим синдромом с использовани ем электрофореза эуфиллина по верхневоротниковой методике f2 J. The closest to the invention is a method of complex resort-climatic treatment of patients with hypothalamic syndrome using aminophylline electrophoresis according to the upper collar technique f2 J.
Однако этот способ, повыша .эффективность лечени , не обеспечивает в достаточной степени положительного действи лечебного комплекса при нарушени х обменных процессов (липндный , холестериновый, углеводный об .мен), при влени х гиперкоагул ции в свертывающей системе крови, при некоторых нейрогуморальных расстройстo вах.However, this method, increasing the effectiveness of treatment, does not provide a sufficient degree of positive effect of the therapeutic complex in case of metabolic disturbances (lipid, cholesterol, carbohydrate metabolism), in cases of hypercoagulation in the blood coagulation system, and in some neurohumoral disorders.
Цель изобретени - повышение эффективности лечени шпоталамического синдрома с гемодинамическими .церебральными расстройствами.The purpose of the invention is to increase the effectiveness of treatment of sphotalamic syndrome with hemodynamic cerebral disorders.
5five
Цель дос игаетс тем, что при способе лечени больных гипоталамическим синдромом, основанном на использовании электрофореза по верхневоротниковой методике, одновременно с электрс)форе0 зом воротниковой области провод т ,..; электрофорез по сничной области, причем дл воротниковой области используют эуфиллин, а дл по сничной - раствор йода.The goal is achieved by the fact that, in the method of treating patients with the hypothalamic syndrome, based on the use of electrophoresis according to the upper collar technique, simultaneously with electrophoresis, the collar area is carried out; electrophoresis in the lumbar region, and aminophylline is used for the collar region and iodine solution for the lumbar region.
5five
Процедуры можно сочетать с воздушными ваннами, лечебной физкультурой, и весь комплекс полезно дополн ть курсом кислородных ванн, ультрафиолетовыми искусственными или солнечными Procedures can be combined with air baths, physical therapy, and the whole complex is useful to complement the course of oxygen baths, ultraviolet artificial or solar
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU752183910A SU812298A1 (en) | 1975-10-24 | 1975-10-24 | Method of treating patients with hypotolamyc syndrome |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU752183910A SU812298A1 (en) | 1975-10-24 | 1975-10-24 | Method of treating patients with hypotolamyc syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU812298A1 true SU812298A1 (en) | 1981-03-15 |
Family
ID=20635507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU752183910A SU812298A1 (en) | 1975-10-24 | 1975-10-24 | Method of treating patients with hypotolamyc syndrome |
Country Status (1)
| Country | Link |
|---|---|
| SU (1) | SU812298A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2352365C1 (en) * | 2007-08-06 | 2009-04-20 | Ирина Николаевна Андреева | Method of treatment of diencephalic syndrome of pubertal period |
-
1975
- 1975-10-24 SU SU752183910A patent/SU812298A1/en active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2352365C1 (en) * | 2007-08-06 | 2009-04-20 | Ирина Николаевна Андреева | Method of treatment of diencephalic syndrome of pubertal period |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gordon et al. | Sodium salicylate iontophoresis in the treatment of plantar warts | |
| SU812298A1 (en) | Method of treating patients with hypotolamyc syndrome | |
| RU2045291C1 (en) | Method for treating polyneuropathy | |
| RU2063782C1 (en) | Method and device for treating eye diseases and postoperative ophthalmic patients resuscitation | |
| RU2025144C1 (en) | High-voltage electrotherapy method | |
| RU2637618C1 (en) | Method for physiotherapeutic treatment of vertigo | |
| RU2360676C1 (en) | Therapy of patients suffering from pancreatic diabetes combined with central nervous system damage | |
| RU2526475C1 (en) | Method of physiotherapeutic treatment of patients with diabetic neuropathy of lower extremities | |
| RU2456030C1 (en) | Method of treating osteoarthrosis with underlying hypertension | |
| SU1271514A1 (en) | Method of treament of patients with insufficient blood circulation of brain | |
| Shepley et al. | The clinical applications of electrically induced convulsions | |
| RU2474411C1 (en) | Method of treating patients with diabetic angiopathy of lower extremities | |
| RU2794433C1 (en) | Method for treatment of patients with chronic fatigue syndrome | |
| SU1146058A1 (en) | Method of treatment of patient ill with lumbosacral radiculitis | |
| SU628918A1 (en) | Method of treating patients suffering from chronic pyelonephritis | |
| RU2014850C1 (en) | Method of treating myotonic spasms | |
| RU2174417C2 (en) | Method for treating cardiac ischemia disease in preparative period before aortocoronary bypass operation | |
| SU418193A1 (en) | ||
| RU2365387C1 (en) | Method of treatment of patients after acute stroke | |
| SU1764661A1 (en) | Bandage for balneologic procedure | |
| RU2372888C1 (en) | Method of health resort therapy in patients with minor craniocerebral injury in early recovery period | |
| SU889012A1 (en) | Method of treating chronic and near-acute vessel deseases and peripheral nerve deseases | |
| SU413950A1 (en) | ||
| SU418194A1 (en) | ||
| RU2457007C2 (en) | Method of treating patients suffering coxarthrosis |